EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Utilization of Fertility Treatment in Japan During the First Year of Insurance Coverage: Analysis of Real‐World Health Claims Data

Makoto Okawara iD, Tomoichiro Kuwazuru, Moe Masunaga, Kenji Fujimoto iD, Masako Nagata, Takeshi Iwasa, Yoshihisa Fujino

Reproductive Medicine and Biology · 2026-01 · 25 (1)

DOI: 10.1002/rmb2.70033 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Reproductive Medicine and Biology, online erschienen am 06.03.2026. Verfasst von Makoto Okawara und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Preventive Medicine and Community Health, School of Medicine University of Occupational and Environmental Health, Japan Fukuoka Japan. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

In April 2022, fertility treatments, including assisted reproductive technology (ART), became eligible for public health insurance coverage in Japan. This study describes the prevalence and characteristics of infertility diagnoses and fertility treatments during the first year of coverage.

Methods

This study analyzed claims data from 14 health insurance associations from April 2022 to March 2023. Infertility diagnoses and fertility treatments, and related comorbidities were identified via diagnosis, procedure, and drug codes.

Results

Among 590,006 women and 619,551 men, the highest prevalence of infertility was seen in women (3.9%) and men (0.5%) aged 30–34 years. General fertility treatment was more common among younger women but decreased with age, while ART became more prevalent after age 35. The major prescriptions were hormone preparations for ART and luteal insufficiency among women. The diagnosis ratio of OHSS was higher than previously reported, with 8.0% to 9.6% of women undergoing fertility treatment, particularly receiving ART and younger. Male prevalence of diagnosis and treatment remained low, with multiple factors underlying access to treatment.

Conclusions

Public insurance coverage improved access to fertility treatment and enhanced data standardization in Japan. This study indicates the need for targeted strategies to broaden equity in reproductive health services.

Schlagwörter

Stichwörter der Autor:innen

fertility clinicshealthinfertilityinsurancemedical recordsreproductive techniques

Autor:innen und Institutionen

  • Department of Preventive Medicine and Community Health, School of Medicine University of Occupational and Environmental Health, Japan Fukuoka Japan.
  • Department of Environmental Epidemiology, Institute of Industrial Ecological Sciences University of Occupational and Environmental Health, Japan Fukuoka Japan.
  • Data Science Center for Occupational Health University of Occupational and Environmental Health, Japan Fukuoka Japan.
  • Department of Occupational Medicine, School of Medicine University of Occupational and Environmental Health, Japan Fukuoka Japan.
  • Department of Obstetrics and Gynecology, Institute of Biomedical Sciences Tokushima University Graduate School Tokushima Japan.

ORCID-Profile: Makoto Okawara, Kenji Fujimoto

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Okawara, M., Kuwazuru, T., Masunaga, M., Fujimoto, K., Nagata, M., Iwasa, T., & Fujino, Y. (2026). Utilization of Fertility Treatment in Japan During the First Year of Insurance Coverage: Analysis of Real‐World Health Claims Data. Reproductive Medicine and Biology, 25(1). https://doi.org/10.1002/rmb2.70033

Vancouver

Okawara M, Kuwazuru T, Masunaga M, Fujimoto K, Nagata M, Iwasa T, et al. Utilization of Fertility Treatment in Japan During the First Year of Insurance Coverage: Analysis of Real‐World Health Claims Data. Reproductive Medicine and Biology. 2026;25(1). doi:10.1002/rmb2.70033

BibTeX
@article{Okawara2026,
  author = {Okawara, Makoto and Kuwazuru, Tomoichiro and Masunaga, Moe and Fujimoto, Kenji and Nagata, Masako and Iwasa, Takeshi and Fujino, Yoshihisa},
  title = {Utilization of Fertility Treatment in Japan During the First Year of Insurance Coverage: Analysis of Real‐World Health Claims Data},
  journal = {Reproductive Medicine and Biology},
  year = {2026},
  volume = {25},
  number = {1},
  doi = {10.1002/rmb2.70033}
}
Kostenlos starten →